Maia I. Kelly

Maia I. Kelly

Auto-generated profile, based on publicly available information

Maia I. Kelly

Protea Glycosciences Pty Ltd

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
XHXinyuan He
Xinyuan He
YCYan Chen
Yan Chen
DBDaisy Guiza Beltran
Daisy Guiza Beltran
MKMaia Kelly
Maia Kelly
BMBin Ma
Bin Ma
WNWei Niu
Wei Niu
Protein tyrosine O-sulfation (PTS) plays a crucial role in extracellular biomolecular interactions that dictate various cellular processes. It also involves in the development of many human diseases. Regardless of recent progress, our current understanding of PTS is still in its infancy. To promote and facilitate relevant studies, a generally applicable method is needed to enable efficient expression of sulfoproteins with defined sulfation sites in live mammalian cells. Here we report the engineering, in vitro biochemical characterization, structural study, and in vivo functional verification of a tyrosyl-tRNA synthetase mutant for the genetic encoding of sulfotyrosine in mammalian cells. We further apply this chemical biology tool to cell-based studies on the role of a sulfation site in the activation of chemokine receptor CXCR4 by its ligand. Our work will not only facilitate cellular studies of PTS, but also paves the way for economical production of sulfated proteins as therapeutic agents in mammalian systems.

1 September 2015 in Analytica Chimica Acta
Verified
Journal Article
Closed access
MKMaia I. Kelly
Maia I. Kelly
TBTyler J. Bechtel
Tyler J. Bechtel
DRD. Rajasekhar Reddy
D. Rajasekhar Reddy
EHErome D. Hankore
Erome D. Hankore
JBJon R. Beck
Jon R. Beck
CSCliff I. Stains
Cliff I. Stains

8 April 2021 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Open access
PDF file
MKMaia I. Kelly
Maia I. Kelly
MAMustafa Albahrani
Mustafa Albahrani
CCChase Castro
Chase Castro
EPEllen Poon
Ellen Poon
BYBin Yan
Bin Yan
RGRebekah Gundry
Rebekah Gundry
Proper protein glycosylation is critical to normal cardiomyocyte physiology. Aberrant glycosylation can alter protein localization, structure, drug interactions, and cellular function. The in vitro differentiation of human pluripotent stem cells into cardiomyocytes (hPSC-CM) has become increasingly important to the study of protein function and to the fields of cardiac disease modeling, drug testing, drug discovery, and regenerative medicine. Here, we offer our perspective on the importance of protein glycosylation in hPSC-CM. Protein glycosylation is dynamic in hPSC-CM, but the timing and extent of glycosylation are still poorly defined. We provide new data highlighting how observed changes in hPSC-CM glycosylation may be caused by underlying differences in the protein or transcript abundance of enzymes involved in building and trimming the glycan structures or glycoprotein gene products. We also provide evidence that alternative splicing results in altered sites of glycosylation within the protein sequence. Our findings suggest the need to precisely define protein glycosylation events that may have a critical impact on the function and maturation state of hPSC-CM. Finally, we provide an overview of analytical strategies available for studying protein glycosylation and identify opportunities for the development of new bioinformatic approaches to integrate diverse protein glycosylation data types. We predict that these tools will promote the accurate assessment of protein glycosylation in future studies of hPSC-CM that will ultimately be of significant experimental and clinical benefit.


25 November 2025 in bioRxiv
Verified
Preprint
Open access
MKMaia Kelly
Maia Kelly
CAChristopher Ashwood
Christopher Ashwood
O -glycan analysis faces analytical challenges due to poor fragmentation characteristics of oxidatively released O -glycan acids, which can preserve labile O -acetyl modifications but suffer from charge fixation at the reducing end. This study introduces a supercharging approach using hexafluoroisopropanol (HFIP) and butylamine mobile phase additives for enhanced mass spectrometric analysis of bleach-released O -glycan acids. HFIP/butylamine increased average charge states by up to 50% compared to traditional mobile phases, dramatically improving MS2 fragmentation quality and enabling discrimination between isomeric compositions and structures. Enhanced fragmentation enabled confident identification of sialic acid variants and acetylation patterns, overcoming the analytical bottleneck of poor O -glycan acid fragmentation. Computational optimization reduced database search times by up to ninefold while maintaining sensitivity. Application to multi-species gastric mucins revealed distinct glycosylation profiles. Porcine mucin showed predominant serine-linked neutral structures, while bovine and ovine mucins exhibited primarily threonine-linked sialylated glycans. A minor fraction of porcine and bovine mucins contained acetylated serine-linked sialylated glycans. This methodology provides a comprehensive framework for O -glycan characterization while preserving biological modifications.

14 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MKMaia I. Kelly
Maia I. Kelly
WTW. C. Mike Thang
W. C. Mike Thang
CPC. N. Ignatius Pang
C. N. Ignatius Pang
JGJohan O.R. Gustafsson
Johan O.R. Gustafsson
CAChristopher Ashwood
Christopher Ashwood
Glycans are integral biomolecules whose presence cannot be predicted from genomic data alone, necessitating experimental characterisation through approaches including mass spectrometry. Assignment of glycan compositions to observed mass to charge ratios is computationally challenging due to the potential monosaccharide diversity and existing tools lack the required flexibility for integration into automated bioinformatic workflows. Here, we present GlyComboCLI, an open-source command-line application for the assignment of glycan compositions to mass spectrometry data which expands upon the previous GUI application, GlyCombo. GlyComboCLI accepts mass lists and vendor-neutral mzML files, supports diverse monosaccharides, derivatisation states, reducing-end modifications and adducts, and is validated through automated tests spanning supported search parameters, input formats, and instrument vendors. Outputs are compatible with downstream tools including Skyline and GlycoWorkBench while GlyTouCan accessions support persistent identification of registered base compositions. Deployment as a standalone executable, a Docker container, and a Galaxy tool, supports FAIR and reproducible workflows. Applied to published mouse and human glycomics datasets, GlyComboCLI reproduced major qualitative glycomic motifs and relative abundance trends, while Galaxy workflow reproduced expected effects of sialidase treatment. These results demonstrate a flexible, scalable, and reproducible approach for glycan composition assignment within automated glycomics workflows.